Enhance executive function, improve daily focus, and manage attention-deficit\/hyperactivity disorder (ADHD) effectively with Strattera Capsules (Atomoxetine Hydrochloride)<\/b>. As the premier, gold-standard non-stimulant prescription medication trusted worldwide by psychiatrists and pediatricians, Strattera is indicated for the treatment of ADHD in children, adolescents, and adults. Engineered for individuals who require robust symptom management without the central nervous system stimulant properties of traditional amphetamines or methylphenidate, it provides steady, 24-hour cognitive support and impulse regulation.<\/p>\n
At the core of Strattera is clorhidrato de atomoxetina<\/b>, a potent and highly selective norepinephrine reuptake inhibitor (SNRI). Unlike stimulant medications that primarily surge dopamine and norepinephrine levels rapidly, atomoxetine works by selectively binding to the presynaptic norepinephrine transporter, blocking its reuptake and significantly increasing extracellular norepinephrine and dopamine concentrations specifically within the prefrontal cortex\u2014the brain region governing attention, working memory, organization, and emotional self-control.<\/p>\nKey Engineering and Clinical Highlights<\/h3>\n
Manufactured under strict pharmaceutical controls to ensure consistent systemic bioavailability, precise micro-dosing, and reliable therapeutic potency, Strattera delivers rigorous clinical performance:<\/p>\n
Non-Stimulant Profile:<\/b> Operates without the classic central nervous system stimulant side effects, significantly reducing risks of insomnia, jitteriness, appetite suppression, and abuse potential.<\/p>\n<\/li>\n Continuous 24-Hour Coverage:<\/b> Formulated for daily administration to provide sustained, baseline prefrontal cortex optimization rather than sharp peaks and valleys.<\/p>\n<\/li>\n Targeted Prefrontal Cortex Action:<\/b> Selectively boosts norepinephrine and dopamine levels in critical executive-function networks to improve sustained attention and impulse control.<\/p>\n<\/li>\n Comprehensive Dosage Range:<\/b> Available in a granular array of 10mg, 18mg, 25mg, 40mg, 60mg, 80mg, and 100mg capsule strengths to facilitate precise weight-based pediatric titration and adult dose optimization.<\/p>\n<\/li>\n<\/ul>\n When psychiatric protocols and personal health requirements demand an effective, non-habit-forming medication to sharpen focus, reduce hyperactivity, and support daily productivity, Strattera stands out as the ultimate frontline therapeutic standard.<\/p>\n Sustained Executive Clarity:<\/b> Helps organize thought patterns, reduces distractibility, and improves task completion throughout the day and evening.<\/p>\n<\/li>\n Low Abuse Liability:<\/b> Classified as a non-controlled substance, making it an ideal choice for patients and clinicians seeking reliable ADHD management without dependency concerns.<\/p>\n<\/li>\n<\/ul>\n Product Type:<\/b> Prescription Non-Stimulant Selective Norepinephrine Reuptake Inhibitor (SNRI)<\/p>\n<\/li>\n Active Ingredient:<\/b> Atomoxetine Hydrochloride (Available in 10mg, 18mg, 25mg, 40mg, 60mg, 80mg, and 100mg capsules)<\/p>\n<\/li>\n Indication:<\/b> Treatment of Attention-Deficit\/Hyperactivity Disorder (ADHD) in Pediatric and Adult Populations<\/p>\n<\/li>\n Packaging:<\/b> Pharmaceutical Blister Packs or Dispensing Bottles (Standard monthly supply cartons)<\/p>\n<\/li>\n Administration Route:<\/b> Oral Capsule (Can be taken once daily in the morning or divided into equal morning and late afternoon\/early evening doses)<\/p>\n<\/li>\n Condition:<\/b> Brand New Pharmaceutical Grade (Requires Strict Prescription and Medical Supervision)<\/p>\n<\/li>\n<\/ul>\n\n The Definitive Global Standard in Non-Stimulant ADHD Care<\/h3>\n
Caracter\u00edsticas y beneficios clave<\/h3>\n
\n
Specifications<\/h2>\n
\n